Pyxis Oncology Inc. (PYXS)
NASDAQ: PYXSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.01 -0.01%
PYXS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $240.11M
- EPS (TTM)
- -$1.40
- Dividend yield
- None
- 52-week range
- 1.03 – 5.55
- Day range
- 2.00 – 2.09
- Volume / Avg
- 957.67K / 1.26M
- Beta
- —
- Shares outstanding
- 119.46M
- Next earnings
- Nov 2, 2026
52-week range
PYXS stock today
On Oct 7, PYXS ended the session at $2.01, shedding $0.01 (0.50%), versus the S&P 500's 0.22% decline. At this level, PYXS sits in the middle of its 52-week range of $1.03 to $5.55: 63.8% below the high, set on Nov 26, 2025 and 95.1% above the low. PYXS is up 74.8% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 21.2%.
Pyxis Oncology has posted a net loss over the last twelve months (EPS of -$1.40), so its P/E ratio is not meaningful. Pyxis Oncology's next earnings report is expected on Nov 2, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Pyxis Oncology
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 2, 2026
- EPS estimate
- $-0.27
Pyxis Oncology peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CAMPCAMP4 Therapeutics Corporation | 3.84 | -3.03% | $240.97M | vs PYXS |
| VOGXVogenx Inc | 16.16 | -1.40% | $240.06M | vs PYXS |
| AKBAAkebia Therapeutics Inc. | 0.8734 | -0.58% | $242.02M | vs PYXS |
| QTTBQ32 Bio Inc. | 7.99 | -1.48% | $237.86M | vs PYXS |
| VCREVicore Pharma Holding AB ADR | 8.66 | -2.74% | $243.90M | vs PYXS |
| LFCRLifecore Biomedical Inc. | 6.44 | -0.15% | $244.11M | vs PYXS |
| SLGLSol-Gel Technologies Ltd. | 71.95 | -4.88% | $235.55M | vs PYXS |
| SIGASIGA Technologies Inc. | 3.26 | -0.91% | $234.23M | vs PYXS |
Indexes, lists and sector
Pyxis Oncology stock FAQ
What is Pyxis Oncology's stock price today?
PYXS last traded at $2.01 as of Oct 7, 4:00 PM EDT, down 0.50% on the day. Prices are delayed at least 15 minutes.
When is Pyxis Oncology's next earnings date?
Pyxis Oncology is expected to report earnings on Monday, November 2, 2026. Analysts expect EPS of $-0.27.
What is the PYXS 52-week high?
The 52-week high for PYXS is $5.55 and the 52-week low is $1.03. The stock is currently 63.8% below its high.